Forecasts data is unavailable for this security.
Consensus recommendation
- 18-Jul-24
- 15-Aug-24
- 19-Sep-24
Select bar for recommendation details.
Recommendations | 19-Sep-24 | |
---|---|---|
Buy | 0 | |
Outperform | 1 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 1 |
Share price forecast in EUR
The 3 analysts offering 12 month price targets for Herantis Pharma Oyj have a median target of 2.20, with a high estimate of 2.90 and a low estimate of 0.70. The median estimate represents a 47.16% increase from the last price of 1.50.
High | 94.0% | 2.90 |
Med | 47.2% | 2.20 |
Low | -53.2% | 0.70 |
Earnings history & estimates in EUR
Average growth rate | -25.87% |
More ▼
Revenue history & estimates in EUR
Average growth rate | 0.00% |
More ▼